Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/12/24
End: 02/28/26
Due: 02/28/27
Phase: N/A
Priority: Normal
Start: 02/17/21
End: 05/16/22
Due: 05/16/23
Phase: N/A
Priority: Normal
Start: 11/05/24
End: 03/31/26
Due: 03/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Phase 2 Study to Evaluate the Efficacy and Safety of ENN0403 in Subjects with DME | NCT06708260 | EnnovaBio | user2@example.com | None | 2024-12-12 | 2026-02-28 | 2027-02-28 | - | - | 2025-07-14 |
| A First-in-human Single Ascending Dose/Multiple Ascending Dose Study of ENN0403 in Healthy Subjects | NCT05506540 | EnnovaBio | user2@example.com | None | 2021-02-17 | 2022-05-16 | 2023-05-16 | - | - | 2025-07-14 |
| Efficacy and Safety of ENN0403 in Patients At High Risk for Acute Kidney Injury Following Elective Cardiac Surgery | NCT06632613 | EnnovaBio | user2@example.com | None | 2024-11-05 | 2026-03-31 | 2027-03-31 | - | - | 2025-07-14 |